Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Startups & Unicorns companies in Imipenem
by Most Market Reports in the world in 2022

The Imipenem top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Market Reports Imipenem Startups & Unicorns in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Imipenem (Primaxin among others) is an intravenous β-lactam antibiotic discovered by Merck scientists Burton Christensen, William Leanza, and Kenneth Wildonger in the mid-1970s. Carbapenems are highly resistant to the β-lactamase enzymes produced by many multiple drug-resistant Gram-negative bacteria, thus play a key role in the treatment of infections not readily treated with other antibiotics.
#
Company Name
Region
Tech Topics
Total
1
Karnataka, India
market report: 1
2
Baden-Württemberg, Germany
market report: 1
3
Synthetic biology,Health care,Fidaxomicin,
...[+2]
market report: 1
4
Île-de-France, France
Antimicrobial,Health care,CRISPR,
...[+2]
market report: 1
5
Epoxide,Medicine,Health care,
...[+2]
market report: 1
6
Clinical trial,Software,Health care,
...[+2]
market report: 1
7
Antibiotics,Health care,Pharmacy and Therapeutics,
...[+2]
market report: 1
8
Hovedstaden, Denmark
market report: 1
9
Talon Pharmaceutical Services, Inc.
Ontario, Canada
market report: 1
10
Alberta, Canada
Antibiotics,Health care,Cephalosporin,
...[+2]
market report: 1
Page generation time: Apr 26 2025